BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26359995)

  • 1. Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow.
    Dong M; Mu N; Ren F; Li F; Zhang C; Yang J
    Am J Med Sci; 2015 Nov; 350(5):352-6. PubMed ID: 26359995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI.
    Arslan U; Yaman M; Kocaoğlu İ; Turan OE; Yücel H; Aksakal A; Günaydin İA; Hakan Ateş A
    Coron Artery Dis; 2015 Sep; 26(6):510-5. PubMed ID: 26086864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
    Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2009 Aug; 54(1):36-44. PubMed ID: 19632518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
    Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
    Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
    Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
    Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
    Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Avanzas P; Bosa-Ojeda F; Kaski JC
    Am J Cardiol; 2010 Dec; 106(11):1540-4. PubMed ID: 21094352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction.
    Funayama H; Ishikawa SE; Sugawara Y; Kubo N; Momomura S; Kawakami M
    Int J Cardiol; 2010 Mar; 139(2):187-92. PubMed ID: 19138806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.